Skip to content

Application of high-intensity interval exercise based on wearable devices in adult patients with type 1 diabetes mellitus

Application of high-intensity interval exercise based on wearable devices in adult patients with type 1 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106995
Enrollment
Unknown
Registered
2025-08-01
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes

Interventions

Control group:Conventional nursing mode
Experimental group:High-intensity intermittent exercise based on smart phone APP combined with wearable devices

Sponsors

The first affiliated Hospital of henan university of science & technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for T1DM in the "Chinese Guidelines for the Diagnosis and Treatment of T1DM (2021 Edition)" 2. Age>=18 years 3.7.00 %<=HbA1c<=10.00 % 4. Be proficient in using a smartphone and be able to install APP software 5. Have good cognitive and communication skills 6. Participants give informed consent and sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Screening of the Holistic Group Strength Activity Readiness Questionnaire (PAR-Q) and the Physical Function Risk Assessment Scale (SFMA), and there is a risk of exercise. 2. Those with any contraindications to exercise: chronic complications such as severe heart, kidney, eye, nerve and foot lesions (proliferative retinopathy, renal disease stage III or above, severe cardiovascular and cerebrovascular system diseases, joint lesions, limited physical activity, hypertension of grade 2 or above, and multiple fasting blood glucose >=16.70 mmol/L, etc.) 3. Patients with diabetic ketoacidosis or severe hypoglycemic events (defined as: requiring assistance with carbohydrate intake, glucagon injections, or other resuscitation therapy) within the past 1 month.

Design outcomes

Primary

MeasureTime frame
Time in Range(TIR);

Secondary

MeasureTime frame
Triglycerides;The duration and proportion of non-rapid eye movement sleep stage N2;Total cholesterol;Fasting blood-glucose;Low-Density Lipoprotein Cholesterol;Wake time after sleep onset (WASO);Progressive load exercise for cardiopulmonary endurance.;The duration and proportion of non-rapid eye movement sleep N1 stage;Time Below Range(TBR);The duration and proportion of non-rapid eye movement sleep stage N3;Total sleep time(TST);Blood glucose coefficient of variation(CV);Rating of Perceived Exertion Scale(RPE);glycosylated hemoglobin;The duration and proportion of sleep during rapid eye movement sleep;Time Above Range(TAR);mean glucose(MG);Clarke Questionnaire Score;Score of the Exercise Self-Efficacy Scale;Gold score;Sleep latency(SL);Pittsburgh Sleep Quality Index Scale score(PSQI);High-Density Lipoprotein Cholesterol;The duration and proportion of non-rapid eye movement sleep stage N4;

Countries

China

Contacts

Public ContactLiu Fangfang

The first affiliated Hospital of henan university of science & technology

15226027938@163.com+86 379 6982 3080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026